Influenza vaccination and associated factors among Korean cancer survivors : a cross-sectional analysis of the Fourth & Fifth Korea National Health and Nutrition Examination Surveys.

Kyung-Hyun Choi, Sang Min Park, Kiheon Lee, Ju Hyun Lee, Joo-Sung Park
Author Information
  1. Kyung-Hyun Choi: Center for Health Promotion & Cancer Prevention, Dongnam Institute of Radiological & Medical Sciences, Busan, Korea. ORCID
  2. Sang Min Park: Department of Family Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea. ORCID
  3. Kiheon Lee: JW LEE Center for Global Medicine and Department of Family Medicine, Seoul National University College of Medicine and Seoul National University Bundang Hospital, Seongnam, Korea. ORCID
  4. Ju Hyun Lee: Department of Family Medicine, National Police Hospital, Seoul, Korea. ORCID
  5. Joo-Sung Park: Department of Family Medicine, Dong-A University College of Medicine, Busan, Korea. ORCID

Abstract

Influenza vaccination is important for cancer survivors, a population with impaired immunity. This study was designed to assess influenza vaccination patterns among Korean cancer survivors. In this cross-sectional analysis, data were obtained from standardized questionnaires from 943 cancer survivors and 41,233 non-cancer survivors who participated in the Fourth and Fifth Korea National Health and Nutrition Examination Surveys (2007-2011). We identified the adjusted influenza vaccination rates and assessed factors associated with influenza vaccination using multivariate logistic regression. Cancer survivors tended to have a higher adjusted influenza vaccination rate than the general population. The rates for influenza vaccination in specific cancer types such as stomach, hepatic, colon, and lung cancers were significantly higher than non-cancer survivors. Among all cancer survivors, those with chronic diseases, elderly subjects, and rural dwellers were more likely to receive influenza vaccination; those with cervical cancer were less likely to receive influenza vaccination. Cancer survivors were more likely to receive influenza vaccinations than non-cancer survivors, but this was not true for particular groups, especially younger cancer survivors. Cancer survivors represent a sharply growing population; therefore, immunization against influenza among cancer survivors should be concerned as their significant preventative healthcare services.

Keywords

References

  1. Nicotine Tob Res. 2012 Feb;14(2):123-30 [PMID: 22180595]
  2. Med Oncol. 2002;19(2):71-8 [PMID: 12180483]
  3. CA Cancer J Clin. 2012 Jan-Feb;62(1):10-29 [PMID: 22237781]
  4. J Natl Compr Canc Netw. 2008 Feb;6(2):215-22 [PMID: 18319053]
  5. Clinics (Sao Paulo). 2012;67(4):313-8 [PMID: 22522755]
  6. J Clin Nurs. 2009 Apr;18(7):960-71 [PMID: 19207795]
  7. J Gen Intern Med. 2009 Apr;24(4):469-74 [PMID: 19156470]
  8. PLoS One. 2010 Nov 30;5(11):e14158 [PMID: 21152402]
  9. Prev Chronic Dis. 2010 Jan;7(1):A09 [PMID: 20040224]
  10. Am J Prev Med. 2001 Jan;20(1):21-5 [PMID: 11137770]
  11. BMC Cancer. 2012 Nov 26;12:557 [PMID: 23181637]
  12. J Am Board Fam Med. 2011 Jan-Feb;24(1):57-68 [PMID: 21209345]
  13. Lancet Infect Dis. 2009 Aug;9(8):493-504 [PMID: 19628174]
  14. Cancer. 2007 Jun 1;109(11):2357-64 [PMID: 17457827]
  15. Influenza Other Respir Viruses. 2012 Nov;6(6):e120-8 [PMID: 22574786]
  16. Public Health. 2009 Oct;123(10):665-9 [PMID: 19854457]
  17. J Korean Med Sci. 2011 Jan;26(1):22-7 [PMID: 21218025]
  18. Public Health. 2010 Dec;124(12):690-7 [PMID: 21035825]
  19. Am J Prev Med. 2010 Jan;38(1):61-9 [PMID: 20117558]
  20. J Cancer Surviv. 2011 Sep;5(3):283-91 [PMID: 21553320]
  21. J Clin Oncol. 2008 Mar 1;26(7):1073-9 [PMID: 18309941]
  22. Prev Med. 2012 May;54(5):358-62 [PMID: 22465670]
  23. Ann Oncol. 2008 Sep;19(9):1658 [PMID: 18662953]
  24. Health Rep. 2007 Nov;18(4):9-19 [PMID: 18074993]
  25. J Gen Intern Med. 2008 Mar;23(3):254-9 [PMID: 18197456]
  26. Am J Epidemiol. 2000 Apr 15;151(8):773-80 [PMID: 10965974]
  27. MMWR Recomm Rep. 1996 May 3;45(RR-5):1-24 [PMID: 8606679]
  28. Cancer. 2005 Aug 1;104(3):618-28 [PMID: 15973737]
  29. BMC Public Health. 2013 Apr 25;13:388 [PMID: 23617788]
  30. Eur J Cancer Prev. 2008 Oct;17(5):453-9 [PMID: 18714188]
  31. MMWR Surveill Summ. 2012 Jan 20;61(1):1-23 [PMID: 22258477]
  32. Ann Pharmacother. 2002 Jul-Aug;36(7-8):1219-29 [PMID: 12086557]
  33. J Oncol Pharm Pract. 2006 Sep;12(3):143-54 [PMID: 17022869]
  34. Cancer Res Treat. 2011 Mar;43(1):1-11 [PMID: 21509157]
  35. Korean J Intern Med. 2014 Mar;29(2):265-80 [PMID: 24648817]
  36. MMWR Recomm Rep. 2009 Jul 31;58(RR-8):1-52 [PMID: 19644442]
  37. Int J Clin Pract. 2003 Jul-Aug;57(6):542-3 [PMID: 12918895]
  38. J Support Oncol. 2011 Jul-Aug;9(4):156-60 [PMID: 21809521]

MeSH Term

Adult
Age Distribution
Aged
Aged, 80 and over
Comorbidity
Disease Susceptibility
Educational Status
Female
Health Behavior
Humans
Influenza Vaccines
Influenza, Human
Male
Mass Vaccination
Middle Aged
Neoplasms
Republic of Korea
Risk Factors
Sex Distribution
Social Class
Survival Rate
Survivors

Chemicals

Influenza Vaccines

Word Cloud

Created with Highcharts 10.0.0survivorsvaccinationcancerinfluenzaCancerInfluenzapopulationamongKoreannon-cancerlikelyreceivecross-sectionalanalysisFourthFifthKoreaNationalHealthNutritionExaminationSurveysadjustedratesfactorsassociatedhigherimportantimpairedimmunitystudydesignedassesspatternsdataobtainedstandardizedquestionnaires94341233participated2007-2011identifiedassessedusingmultivariatelogisticregressiontendedrategeneralspecifictypesstomachhepaticcolonlungcancerssignificantlyAmongchronicdiseaseselderlysubjectsruraldwellerscervicallessvaccinationstrueparticulargroupsespeciallyyoungerrepresentsharplygrowingthereforeimmunizationconcernedsignificantpreventativehealthcareservices:&SurvivorsVaccines

Similar Articles

Cited By